SEC Form 4 · accession 0001144204-15-053655
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charlotte C. Arnold
Officer — Vice President and CFO
Period of report
Sep 2, 2015
Accepted (ET)
Sep 3, 2015 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 2, 2015 | M | 2,106 | $33.00 | A | 31,038 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock | $33.00 | Sep 2, 2015 | M | 2,106 | D | Apr 1, 2015 | Mar 31, 2024 | Common Stock | 2,106 | 9,894 | D |